Another multinational jumping on the bandwagon of China's flourishing high-tech industry is the global healthcare giant Novo Nordisk. During the past two decades, the Danish company has expanded its ...

Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

Novo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its bumper weight ...

Thammasat University Hospital and Novo Nordisk Pharma (Thailand) Ltd. have launched a new collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Copenhagen Infrastructure Partners (CIP), through its Growth Markets Fund II, has signed an agreement with ACEN, the listed energy platform of the Ayala Group, to sell a 25% minority stake in the ...